BioPhenyx ApS
CVR 42954810 · Private limited company (ApS) · Active · Low risk
BioPhenyx ApS is a Private limited company (ApS), founded on , based in Frederiksberg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 4 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (30 Jun 2026) shows equity of DKK -90k and a net result of DKK 102k. CEO: Ole Bitsch-Jensen, Morten Frödin, Casper Carstens Lund, Tomas Eriksson.
Bankruptcy risk for BioPhenyx ApS
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 42954810
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- Nordre Fasanvej 215
2000 Frederiksberg - Municipality
- Frederiksberg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 40k
- Auditor
- PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 4 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -39.9% |
| Current ratio | 72% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 111 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Gross profit | DKK 113k | DKK 5,532 | DKK -269k |
| Net profit | DKK 102k | DKK -7,280 | DKK -270k |
| Equity | DKK -90k | DKK -192k | DKK -184k |
| Total assets | DKK 225k | DKK 12k | DKK 43k |
| Cash | DKK 155k | DKK 2,901 | – |
| Short-term debt | DKK 315k | DKK 203k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jul 2025 – 30 Jun 2026 | 66 | ||
| 1 Jul 2024 – 30 Jun 2025 | 184 | Late | |
| 1 Jul 2023 – 30 Jun 2024 | 180 | ||
| 6 Jan 2022 – 30 Jun 2023 | 153 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Ole Bitsch-Jensen | Current | |
| CEO | Morten Frödin | Current | |
| CEO | Casper Carstens Lund | Current | |
| CEO | Tomas Eriksson | Current | |
| CEO | Claus Storgaard Sørensen | ||
| Owner (100%) | Phenyx Holding ApS | Current | |
| Auditor | PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab | ||
| Founder | Phenyx Holding ApS | Current |
The CEOs' other companies
Ole Bitsch-Jensen – 18 other companies, of which 6 bankrupt
- Asiros Nordic A/S Bankrupt 3 Sep 2024
- CURIX ApS Bankrupt 27 Nov 2013
- CYTOTRACK ApS Bankrupt 18 Jan 2022
- ONCONOX ApS Bankrupt 18 Mar 2026
- PHARMA 2100 ApS Bankrupt 16 Mar 2018
- STX PHARMACEUTICALS ApS Bankrupt 29 Apr 2014
- 2cureX A/S Active
- AROS PHARMA ApS Opløst
- FLUIMEDIX ApS Active
- HELION BIOTECH ApS Active
- MEDIC ADVICE ApS Opløst
- MEDICOMETRICS ApS Opløst
- MINERVAX ApS Active
- Phenyx Holding ApS Active
- Ranger Biotechnologies A/S Active
- Selectedbotanicals A/S Active
- VALDERM ApS Opløst
- VICTORIOUS MEDICAL SYSTEMS ApS Active
Morten Frödin – 1 other companies
- Phenyx Holding ApS Active
Casper Carstens Lund – 1 other companies
- Phenyx Holding ApS Active
Claus Storgaard Sørensen – 1 other companies
- Phenyx Holding ApS Active
Address history (1 moves)
| Nordre Fasanvej 215, 2000 Frederiksberg | |
| Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- Nordetect ApS Bankrupt
- ACESION PHARMA ApS Active
- AdaptVac ApS Active
- Adcendo ApS Active
- Akylox Therapeutics ApS Active
- Antraka ApS Opløst
- Augustine Therapeutics Denmark ApS Active
- Autocert ApS Active
- Avancert ApS Active
- B4C ApS Active
- BOOST Pharma ApS Active
- Baekmark IP Consult ApS Active
- Betula Capital ApS Active
- Biobridge Partners ApS Active
- Biotinia ApS Active
- CMCAssist ApS Active
- CMCGreenhouse ApS Active
- CMCHoldings ApS Active
- CaMaRa ApS Active
- Catalyst Vaccination A/S Active
- Chris Cording Jønsson Holding ApS Active
- DARERL ApS Active
- DFY ApS Active
- DeltaBot ApS Active
- Details ApS Active
Similar companies in Frederiksberg
- Catalyst Vaccination A/S Frederiksberg
- RefuelBio ApS Frederiksberg
- BioMomentum Advisors ApS Frederiksberg
- Oak Mountain Consulting ApS Frederiksberg
- Biotinia ApS Frederiksberg
- Nordic BioVentures ApS Frederiksberg C
- Zevra Denmark A/S Frederiksberg
- BioSpringbok ApS Frederiksberg
- Orbis Medicines ApS Frederiksberg
- Epoqe Pharma ApS Frederiksberg
- SJM IP ApS Frederiksberg C
- Pephexia Therapeutics ApS Frederiksberg
Questions and answers about BioPhenyx ApS
Has BioPhenyx ApS gone bankrupt?
No, BioPhenyx ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of BioPhenyx ApS?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of BioPhenyx ApS?
Ole Bitsch-Jensen, Morten Frödin, Casper Carstens Lund, Tomas Eriksson are the CEOs of BioPhenyx ApS.
Who is the auditor of BioPhenyx ApS?
BioPhenyx ApS most recently used PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab.
When was BioPhenyx ApS founded?
BioPhenyx ApS was founded on 6 January 2022.
What is the equity of BioPhenyx ApS?
Equity was DKK -90k according to the annual report for the period ending 30 June 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.